Virtu Financial LLC Contrafect Corp Transaction History

Virtu Financial LLC

  • $1.43 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 15, 2023
BUY
$0.09 - $0.19 $8,016 - $16,923
89,069 Added 48.89%
271,242 $26,000
Q3 2022

Nov 07, 2022
BUY
$0.18 - $3.51 $32,791 - $639,427
182,173 New
182,173 $31,000
Q3 2021

Nov 12, 2021
SELL
$3.19 - $4.43 $63,535 - $88,232
-19,917 Closed
0 $0
Q2 2021

Sep 17, 2021
BUY
$3.58 - $4.9 $71,302 - $97,593
19,917 New
19,917 $88,000

Others Institutions Holding CFRX

# of Institutions
2
Shares Held
49.2K
Call Options Held
0
Put Options Held
0
View Full List

About CONTRAFECT Corp

CFRX Quotes by TradingView
  • Ticker CFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,332,700
  • Market Cap $1.18M
  • Description
  • ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus...
More about CFRX
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email